PRESTIGE BIOPHARMA, Singapore
Clinical Development
Regulatory Approval
Commercialization
Global campus for an innovative R&D ecosystem
Prestige Biopharma accelerates innovation through its global R&D campus in Singapore.
Established in 2015, the headquarters is a global R&D hub for translating internal pipelines into commercial success.
Pipeline Management
provides integrated oversight across development functions to ensure phase-appropriate progression from early development through registration and lifecycle management.
By aligning CMC, regulatory, clinical, safety, data, and strategic functions within a unified model, IPM enables disciplined execution and informed decision-making, supporting scalable and sustainable pipeline growth.
provides centralized quality governance and end-to-end oversight across global pipelines, sites, and partners. Through harmonized standards, risk-based oversight, and proactive inspection readiness, GQM ensures consistent global GxP implementation and compliant product development worldwide.
& Analytical Science
delivers centralized CMC and analytical expertise from early discovery through commercialization. By integrating bioassay, physicochemical, and analytical capabilities within a cross-functional framework, GCAS ensures robust data generation, regulatory-aligned execution, and accelerated development timelines.